Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06346600 · ClinicalTrials.gov registry record
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
A clinical trial of Neovascular (Wet) Age-Related Macular Degeneration, sponsored by Skyline Therapeutics.
- Recruiting
- Registry status
- 83
- Enrollment target
- 10
- Study locations
NCT06346600 is a study of Neovascular (Wet) Age-Related Macular Degeneration that is actively recruiting participants, run by Skyline Therapeutics. The registered enrollment target is 83 participants. The trial reports 10 study locations across 6 states.
The verdict
NCT06346600, a study of Neovascular (Wet) Age-Related Macular Degeneration, is actively recruiting participants, sponsored by Skyline Therapeutics.
- RECRUITING
- Registry status
- 83 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.
Conditions Studied
Interventions
- GENETIC SKG0106
Study Locations (10)
Other
- Beijing Hospital - Beijing
- Peking Union Medical College Hospital - Beijing
- EYE & ENT Hospital of Fudan University - Shanghai
- Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine - Shanghai
Zhejiang
- Zhejiang Provincial People's Hospital - Hangzhou
- Eye Hospital, WMU (Zhejiang Eye Hospital) - Wenzhou
Massachusetts
- Ophthalmic Consultants of Boston - Boston
Texas
- Retina Consultants of Texas - Katy
Virginia
- Wagner Macula & Retina Center - Norfolk
Anhui
- The Second Hospital Of Anhui Medical University - Hefei
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2024-04-02 |
| Est. Completion | 2031-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06346600
The ClinicalTrials.gov registry entry for NCT06346600 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Skyline Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neovascular (Wet) Age-Related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which SKG0106 is the first listed.
NCT06346600 reports 10 study locations spanning 6 distinct geographic areas - top geographies include Other, Zhejiang, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06346600 about?
NCT06346600 is a clinical study titled "A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD". This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and...
What is the current status of trial NCT06346600?
This trial is currently recruiting. The enrollment target is 83 participants. The study started on 2024-04-02. Estimated completion is 2031-03.
What conditions does trial NCT06346600 study?
This clinical trial studies the following conditions: Neovascular (Wet) Age-Related Macular Degeneration.
What interventions are being tested in trial NCT06346600?
The interventions under investigation include: SKG0106 (GENETIC).
Who is sponsoring clinical trial NCT06346600?
This trial is sponsored by Skyline Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06346600 being conducted?
This trial has 10 study locations across Massachusetts, Texas, Virginia, Anhui, Zhejiang. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neovascular (Wet) Age-Related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.